View in EDS

Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional Study.

Saved in:
Bibliographic Details
Title: Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional Study.
Authors: Keam B; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea., Lim DW; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Institute of Molecular and Cell Biology, A*STAR, Singapore, Singapore., Kao HF; National Taiwan University Hospital, National Taiwan University Cancer Center, Taipei, Taiwan., Yeong J; Institute of Molecular and Cell Biology, A*STAR, Singapore, Singapore., Oum C; Lunit, Seoul, Republic of Korea., Lee S; Lunit, Seoul, Republic of Korea., Lim Y; Lunit, Seoul, Republic of Korea., Ali SM; Lunit, Seoul, Republic of Korea., Goh BC; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore., Tan SH; Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore, Singapore.; Oncology Academic Programme, Duke-NUS Medical School, Singapore, Singapore., Hui EP; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong, China.; Department of Clinical Oncology, Phase 1 Clinical Trial Centre, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong SAR, China., Jung HA; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Park KU; Division of Hematology-Oncology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, Republic of Korea., Cho SH; Division of Hematology-Oncology, Department of Internal Medicine, Chonnam National University Hwasun Hospital, Gwangju, Republic of Korea., Lee KW; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Chan ATC; Department of Clinical Oncology, Phase 1 Clinical Trial Centre, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong SAR, China., Ock CY; Lunit, Seoul, Republic of Korea., Ma B; Department of Clinical Oncology, Phase 1 Clinical Trial Centre, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong SAR, China.
Source: JCO global oncology [JCO Glob Oncol] 2026 Apr; Vol. 12 (4), pp. e2500474. Date of Electronic Publication: 2026 Apr 10.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101760170 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2687-8941 (Electronic) Linking ISSN: 26878941 NLM ISO Abbreviation: JCO Glob Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41962059
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Keam+B%22">Keam B</searchLink>; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lim+DW%22">Lim DW</searchLink>; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Institute of Molecular and Cell Biology, A*STAR, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Kao+HF%22">Kao HF</searchLink>; National Taiwan University Hospital, National Taiwan University Cancer Center, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Yeong+J%22">Yeong J</searchLink>; Institute of Molecular and Cell Biology, A*STAR, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Oum+C%22">Oum C</searchLink>; Lunit, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+S%22">Lee S</searchLink>; Lunit, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lim+Y%22">Lim Y</searchLink>; Lunit, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Ali+SM%22">Ali SM</searchLink>; Lunit, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Goh+BC%22">Goh BC</searchLink>; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Tan+SH%22">Tan SH</searchLink>; Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore, Singapore.; Oncology Academic Programme, Duke-NUS Medical School, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Hui+EP%22">Hui EP</searchLink>; State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong, China.; Department of Clinical Oncology, Phase 1 Clinical Trial Centre, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Jung+HA%22">Jung HA</searchLink>; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Park+KU%22">Park KU</searchLink>; Division of Hematology-Oncology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Daegu, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Cho+SH%22">Cho SH</searchLink>; Division of Hematology-Oncology, Department of Internal Medicine, Chonnam National University Hwasun Hospital, Gwangju, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+KW%22">Lee KW</searchLink>; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Chan+ATC%22">Chan ATC</searchLink>; Department of Clinical Oncology, Phase 1 Clinical Trial Centre, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong SAR, China.<br /><searchLink fieldCode="AU" term="%22Ock+CY%22">Ock CY</searchLink>; Lunit, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Ma+B%22">Ma B</searchLink>; Department of Clinical Oncology, Phase 1 Clinical Trial Centre, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong SAR, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101760170%22">JCO global oncology</searchLink> [JCO Glob Oncol] 2026 Apr; Vol. 12 (4), pp. e2500474. <i>Date of Electronic Publication: </i>2026 Apr 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101760170 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2687-8941 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226878941%22">26878941 </searchLink><i>NLM ISO Abbreviation: </i>JCO Glob Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41962059
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/GO-25-00474
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e2500474
    Titles:
      – TitleFull: Distribution of Immune Cells in Tumor Microenvironment Correlates With Checkpoint Inhibitor Response in Nasopharyngeal Carcinoma: A Multiregional Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Keam B
      – PersonEntity:
          Name:
            NameFull: Lim DW
      – PersonEntity:
          Name:
            NameFull: Kao HF
      – PersonEntity:
          Name:
            NameFull: Yeong J
      – PersonEntity:
          Name:
            NameFull: Oum C
      – PersonEntity:
          Name:
            NameFull: Lee S
      – PersonEntity:
          Name:
            NameFull: Lim Y
      – PersonEntity:
          Name:
            NameFull: Ali SM
      – PersonEntity:
          Name:
            NameFull: Goh BC
      – PersonEntity:
          Name:
            NameFull: Tan SH
      – PersonEntity:
          Name:
            NameFull: Hui EP
      – PersonEntity:
          Name:
            NameFull: Jung HA
      – PersonEntity:
          Name:
            NameFull: Park KU
      – PersonEntity:
          Name:
            NameFull: Cho SH
      – PersonEntity:
          Name:
            NameFull: Lee KW
      – PersonEntity:
          Name:
            NameFull: Chan ATC
      – PersonEntity:
          Name:
            NameFull: Ock CY
      – PersonEntity:
          Name:
            NameFull: Ma B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2026 Apr
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2687-8941
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: JCO global oncology
              Type: main
ResultId 1